VIZZA, Carmine Dario
 Distribuzione geografica
Continente #
NA - Nord America 7.093
EU - Europa 3.935
AS - Asia 1.662
SA - Sud America 107
AF - Africa 59
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 5
Totale 12.869
Nazione #
US - Stati Uniti d'America 6.988
IT - Italia 1.840
SG - Singapore 790
SE - Svezia 427
IN - India 389
UA - Ucraina 341
CN - Cina 284
FI - Finlandia 277
DE - Germania 252
RU - Federazione Russa 239
GB - Regno Unito 142
CA - Canada 78
FR - Francia 73
NL - Olanda 66
BG - Bulgaria 60
ID - Indonesia 57
TG - Togo 49
AR - Argentina 48
IE - Irlanda 42
BR - Brasile 40
RO - Romania 32
AT - Austria 26
IR - Iran 25
HK - Hong Kong 23
MX - Messico 23
BE - Belgio 21
CH - Svizzera 21
LT - Lituania 18
GR - Grecia 12
TR - Turchia 12
KR - Corea 11
PH - Filippine 10
TW - Taiwan 10
ES - Italia 9
PL - Polonia 9
JP - Giappone 8
CL - Cile 7
MY - Malesia 7
CO - Colombia 6
AU - Australia 5
PT - Portogallo 5
TH - Thailandia 5
VN - Vietnam 5
AE - Emirati Arabi Uniti 4
EG - Egitto 4
EU - Europa 4
LV - Lettonia 4
PK - Pakistan 4
EC - Ecuador 3
HR - Croazia 3
LB - Libano 3
MA - Marocco 3
NZ - Nuova Zelanda 3
AL - Albania 2
AZ - Azerbaigian 2
BD - Bangladesh 2
EE - Estonia 2
IL - Israele 2
IQ - Iraq 2
KG - Kirghizistan 2
LU - Lussemburgo 2
NO - Norvegia 2
SK - Slovacchia (Repubblica Slovacca) 2
VE - Venezuela 2
ZA - Sudafrica 2
A1 - Anonimo 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BZ - Belize 1
CR - Costa Rica 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
JM - Giamaica 1
KZ - Kazakistan 1
MD - Moldavia 1
MT - Malta 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
SC - Seychelles 1
SI - Slovenia 1
UZ - Uzbekistan 1
Totale 12.869
Città #
Fairfield 931
Singapore 554
Chandler 541
Rome 540
Woodbridge 476
Ashburn 442
Seattle 352
Cambridge 331
Houston 296
Wilmington 296
Ann Arbor 291
Princeton 259
Dearborn 252
Santa Clara 212
Plano 164
Beijing 153
Milan 138
Jacksonville 119
San Diego 116
San Paolo di Civitate 115
Boston 107
Helsinki 101
Lawrence 101
Millbury 89
Moscow 67
Munich 64
Andover 60
Sofia 59
Des Moines 58
Jakarta 56
Boardman 52
Toronto 52
Lomé 49
New York 49
Federal 45
Dublin 41
Fremont 38
Bremen 37
Norwalk 27
Nuremberg 24
Southend 24
Groningen 23
Lappeenranta 22
London 22
Brussels 21
Falkenstein 21
Naples 21
Yubileyny 21
Mannheim 19
San Mateo 19
Bühl 18
Bologna 16
Falls Church 16
Bergamo 15
Hefei 15
Leawood 15
Florence 14
Turin 14
Bari 13
Klaipėda 13
Kunming 13
Vienna 12
Nanjing 11
Ottawa 11
Paris 10
Grafing 9
Rende 9
Verona 9
Zanjan 9
Beauharnois 8
Catania 8
Dallas 8
Hong Kong 8
Padova 8
Puebla City 8
Pune 8
Stockholm 8
Amsterdam 7
Frankfurt am Main 7
Lowestoft 7
Torino 7
Cardito 6
Central 6
Jinan 6
Marino 6
Mexico City 6
Phoenix 6
Shanghai 6
Temuco 6
Treviso 6
Trieste 6
Athens 5
Atlanta 5
Bogotá 5
Buffalo 5
Chengdu 5
Coyoacán 5
Custonaci 5
Desenzano del Garda 5
Genoa 5
Totale 8.406
Nome #
Significato del sottoslivellamento del tratto ST nelle derivazioni precordiali in corso di infarto miocardico acuto della parete inferiore 731
'Real-life' information on pulmonary arterial hypertension: The iPHnet Project 154
Psychological counselling interventions to improve perceived quality of life and counter anxiety and depression in pulmonary-arterial-hypertension patients. a clinical trial 137
Right ventricular dyssynchrony and exercise capacity in idiopathic pulmonary arterial hypertension 122
Right ventricular concentric hypertrophy and clinical worsening in idiopathic pulmonary arterial hypertension 114
Echocardiography combined with cardiopulmonary exercise testing for the prediction of outcome in idiopathic pulmonary arterial hypertension 107
Sex-specific effects of daily tadalafil on diabetic heart kinetics in RECOGITO, a randomized, double-blind, placebo-controlled trial 106
Letter to the editor about the paper “right ventricular dyssynchrony predicts clinical outcomes in patients with pulmonary hypertension” by murata et al 104
Chronic Inhibition of cGMP Phosphodiesterase 5A Improves Diabetic Cardiomyopathy A Randomized, Controlled Clinical Trial Using Magnetic Resonance Imaging With Myocardial Tagging 103
Long-term safety and efficacy of imatinib in pulmonary arterial hypertension 102
Right heart and pulmonary vessels structure and function 101
Elevated serum levels of macrophage migration inhibitory factor and stem cell growth factor β in patients with idiopathic and systemic sclerosis associated pulmonary arterial hypertension. 99
Prognostic relevance of right heart reverse remodeling in idiopathic pulmonary arterial hypertension 98
Ruolo prognostico a lungo termine dell'ipertensione polmonare nei pazienti con acuta decompensated heart failure : valutazione all'ingresso in ospedale e in pre-dimissione. Roberto Badagliacca, Stefano Ghio, Michele Correale, Pasquale Petrone, Giordana Ferraioli, Beatrice Pezzuto, Roberto Poscia, Laura Scelsi, Giovanna Manzi, Silvia Papa, Daniele Berardi, Ferraretti Armando, Francesco Fedele, Carmine Dario Vizza 97
The added value of cardiopulmonary exercise testing in the follow-up of pulmonary arterial hypertension 94
Transesophageal dipyridamole echocardiography for diagnosis of coronary artery disease. 93
Right ventricular remodeling in idiopathic pulmonary arterial hypertension. adaptive versus maladaptive morphology 92
Human Herpesvirus 8 and Pulmonary Hypertension. 91
Influence of various therapeutic strategies on right ventricular morphology, function and hemodynamics in pulmonary arterial hypertension 90
Cardiovascular effects of chronic sildenafil in men with type 2 diabetes 86
Circulating biomarkers in pulmonary arterial hypertension. update and future direction 86
Pulmonary hemodynamics contribute to indicate priority for lung transplantation in patients with cystic fibrosis 85
Analysis of endothelin-1 and endothelin-1 receptor A gene polymorphisms in patients with pulmonary arterial hypertension. 85
Acute hemodynamic effects of single-dose sildenafil when added to established bosentan therapy in patients with pulmonary arterial hypertension: Results of the COMPASS-1 study 84
Treatment of pulmonary hypertension in patients undergoing cardiac surgery with cardiopulmonary bypass: a randomized, prospective, double-blind study. 83
Ambrisentan for the treatment of adults with pulmonary arterial hypertension. a review 83
Right intraventricular dyssynchrony in idiopathic, heritable, and anorexigen-induced pulmonary arterial hypertension. Cllinical impact and reversibility 83
Abnormal behavior of the forearm vasculature during ergometric test in hypertrophic cardiomyopathy 81
Mortality in pulmonary arterial hypertension. prediction by the 2015 european pulmonary hypertension guidelines risk stratification model 81
Right ventricular strain curve morphology and outcome in idiopathic pulmonary arterial hypertension 81
Tissue-type plasminogen activator therapy versus primary coronary angioplasty: Impact on myocardial tissue perfusion and regional function 1 month after uncomplicated myocardial infarction 80
Right ventricular dyssynchrony in idiopathic pulmonary arterial hypertension: determinants and impact on pump function 79
Increased plasma levels of adrenomedullin, a vasoactive peptide, in patients with end-stage pulmonary disease 78
Usefulness of adding echocardiography of the right heart to risk-assessment scores in prostanoid-treated pulmonary arterial hypertension 77
Pulmonary Arterial Dilatation in Pulmonary Hypertension: Prevalence and Prognostic Relevance 76
Response to letters regarding article, "anticoagulation and survival in pulmonary arterial hypertension: Results from the comparative, prospective registry of newly initiated therapies for pulmonary hypertension (COMPERA)" 76
Systemic sclerosis patients with and without pulmonary arterial hypertension: a nailfold capillaroscopy study 74
Prognostic factors in severe pulmonary hypertension patients who need parenteral prostanoid therapy. the impact of late referral. 73
Changes in Right Ventricular Function Measured by Cardiac Magnetic Resonance Imaging in Patients Receiving Pulmonary Arterial Hypertension-Targeted Therapy The EURO-MR Study 73
Locoregional versus general anesthesia in carotid surgery: Is there an impact on peri-operative myocardial ischemia? Results of a prospective monocentric randomized trial. 73
Haemodynamic effects of an acute vasodilator challenge in heart failure patients with reduced ejection fraction and different forms of post-capillary pulmonary hypertension 73
Sildenafil in severe pulmonary hypertension associated with chronic obstructive pulmonary disease. a randomized controlled multicenter clinical trial 73
An official european respiratory society statement. pulmonary haemodynamics during exercise 73
Demographics, clinical characteristics, health resource utilization and cost of chronic thromboembolic pulmonary hypertension patients: Retrospective results from six European countries 73
Pathophysiological adaptations to walking and cycling in primary pulmonary hypertension 72
Relationship between baseline ET-1 plasma levels and outcome in patients with idiopathic pulmonary hypertension treated with bosentan 72
Clinical impact of echocardiography in prognostic stratification after acute myocardial infarction 71
Tissue viability by contrast echocardiography 71
Improved results with lung transplantation for cystic fibrosis 70
Identification of coronary artery by-pass grafts: reliability of MRI in clinical practice. 70
Plasma adrenomedullin and endothelin-1 concentration during low-dose dobutamine infusion: Relationship between pulmonary uptake and pulmonary vascular pressure/flow characteristics 70
Efficacy of 1, 5, and 20mg oral sildenafil in the treatment of adults with pulmonary arterial hypertension. a randomized, double-blind study with open-label extension 70
Prognostic significance of the echocardiographic estimate of pulmonary hypertension and of right ventricular dysfunction in acute decompensated heart failure. a pilot study in HFrEF patients 70
Heart failure pharmacological management. gaps and current perspectives 69
Usefulness of 2D echo Doppler in the preoperative assessment of cystic fibrosis patients who are candidates for lung transplantation 69
Timing and priorities for cystic fibrosis patients candidates to lung transplantation 68
Usefulness of the dipyridamole-Doppler test for diagnosis of coronary artery disease 68
Cardiovascular effects of chronic sildenafil treatment in men with type 2 diabetes 68
Assessment of right ventricular inotropic reserve during dobutamine infusion in patients with secondary pulmonary hypertension. 67
Effetti Cardiovascolari della Somministrazione in Cronico di Sildenafil in Soggetti con ?Diabete Mellito di tipo 2 67
Long term effects of bosentan treatment in adult patients with pulmonary arterial hypertension related to congenital heart disease (Eisenmenger physiology): Safety, tolerability, clinical, and haemodynamic effect 67
Echo stress in functional evaluation of dilated cardiomyopathy. 67
Comparative Effects of Irbesartan Versus Amlodipine on Left Ventricular Mass Index in Hypertensive Patients with Left Ventricular Hypertrophy 67
Myocardial and microvascular inflammation/infection in patients with HIV-associated pulmonary artery hypertension 67
Cardiac and vascular remodeling after 6 months of therapy with sacubitril/valsartan. mechanistic insights from advanced echocardiographic analysis 67
Preoperative evaluation of patients undergoing lung resection surgery. defining the role of the anesthesiologist on a multidisciplinary team 66
Myocardial and micro-vascular inflammation/infection in HIV/HCV associated pulmonary artery hypertension 66
Supravalvular aortic stenosis and pulmonary artery stenosis: echocardiographic and clinical aspects. 65
Unusual presentation for a patent ductus arteriosus 65
Occult lung cancer in patients with bullous emphysema 65
2019 ESC guidelines for the dignosis and management of acute pulmonary embolism developed in collaboration with the european respiratory society (ERS) 64
Sildenafil dosed concomitantly with bosentan for adult pulmonary arterial hypertension in a randomized controlled trial 63
Acute pulmonary vascular response to inhaled nitric oxide,dobutamine and their association in patients with secondary pulmonary hypertension. 62
Safety and efficacy evaluation of ambrisentan in pulmonary hypertension 62
Endocrine and metabolic alterations in patients with pulmonary arterial hypertension 62
Endogenous opioid system modulation in anginal pain: demonstration of its central activity. 62
Pulmonary arterial hypertension: current therapies. 61
Validità dell'ecocardiografia nella valutazione della terapia cardiovascolare 61
Outcome of Patients with Cystic Fibrosis Awaiting Lung Transplantation 61
Complex connections, a young man presenting with shortness of breath, hypoxemia, right lumbar pain and left limb swelling 61
Dal Tromboembolismo Venoso all’Ipertensione Polmonare cronica tromboembolica 60
Badagliacca R, Papa S, Valli G, Pezzuto B, Poscia R, Murace AC, Marinelli L, Manzi G, Berardi D, Sciomer S, Palange P, Fedele F, Vizza CD. “Incremental benefit of cardiopulmonary exercise testing for the prediction of outcome in stable prevalent idiopathic pulmonary arterial Hypertension patients”. Comunicazione Abstract del 77° Congresso Nazionale della Società Italiana di Cardiologia (2016) 60
Hemodynamics during inhaled nitric oxide in lung transplant candidates 60
The growing role of echocardiography in pulmonary arterial hypertension risk stratification. the missing piece 60
Effects of glucose-insulin-potassium infusion on myocardial perfusion and left ventricular remodeling in patients treated with primary angioplasty for ST-elevation acute myocardial infarction. 59
La terapia di combinazione orale nel trattamento dei pazienti con ipertensione arteriosa polmonare. quali evidenze dagli studi a lungo termine [Oral combination therapy for the treatment of patients with pulmonary arterial hypertension. what evidence from long-term studies] 59
Right ventricular assessment matters for precision medicine.. reply to "Identifying parameters associated with response to switching from a PDE5i to riociguat in RESPITE" 59
Myocardial infarction with non-obstructive coronary arteries (MINOCA. focus on coronary microvascular dysfunction and genetic susceptibility 58
PROSTANOID THERAPY FOR PULMONARY ARTERIAL HYPERTENSION. 58
Pulmonary hypertension in patients with chronic fibrosing idiopathic interstitial pneumonias 58
Studio del tratto "ST" in pazienti sottoposti a TEA carotidea in anestesia locale o generale 58
Medical management of right ventricular dysfunction in pulmonary arterial hypertension 57
Pregnancy outcomes in pulmonary arterial hypertension in the modern management era. 57
Clinical implications of idiopathic pulmonary arterial hypertension phenotypes defined by cluster analysis 57
RESPITE. switching to riociguat in pulmonary arterial hypertension patients with inadequate response to phosphodiesterase-5 inhibitors 57
Peripheral arterial stiffness in acute pulmonary embolism and pulmonary hypertension at short-term follow-up 57
Outcomes of noncardiac, nonobstetric surgery in patients with PAH: an international prospective survey. 56
Prognostic relevance of pulmonary arterial compliance after therapy initiation or escalation in patients with pulmonary arterial hypertension 56
Inhaled areosolized prostacyclin and pulmonary hypertension during anesthesia for lung transplantation 56
Acute hemodynamic effects of inhaled nitric oxide, dobutamine and a combination of the two in patients with mild to moderate secondary pulmonary hypertension. 56
Totale 8.155
Categoria #
all - tutte 50.670
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.670


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020745 0 0 0 0 0 0 0 238 197 150 108 52
2020/20211.195 90 101 43 93 54 94 29 95 203 272 93 28
2021/20222.332 49 130 159 82 245 50 54 186 223 285 411 458
2022/20232.480 461 408 144 261 259 273 25 146 260 45 140 58
2023/20241.573 79 199 90 105 152 160 93 127 27 193 149 199
2024/20252.036 135 214 338 195 300 378 407 69 0 0 0 0
Totale 13.476